-
A newly created position at the University of Pennsylvania Medical Center-Presbyterian in Philadelphia is helping the access department take that next step toward reducing denials and ensuring proper reimbursement, says Raina Harrell, CHAM, director of patient access for business operations.
-
The Joint Commission on Accreditation of Healthcare Organizations has named Swedish Medical Center in Seattle the winner of the inaugural Ernest Amory Codman Award in the disease-specific care category.
-
As a case manager for pediatric cancer patients, Mary Nugent, RN, is challenged with ensuring that her patients get the care and equipment they need when they are out of the hospital, a job that is made more difficult by the scarcity of some of the medications the children are prescribed and the wide range of payers and benefits.
-
-
There have been conflicting reports on the risks of ovarian cancer in users of hormone replacement therapy. In the NIH-AARP Diet and Health Study Cohort, analysis of various aspects of HRT and the development of ovarian cancer in approximately 100,000 women aged 50-71 years was undertaken.
-
-
Wait and see prescriptions (WASP) is a new concept for the treatment of otitis media in children.
-
-
Rituximab has proven an effective adjunct to various chemotherapy regimens in the treatment of lymphoma. When used alone or with combinations such as CHOP, hypogammaglobulinemia occurs relatively infrequently and no increased risk of infection has been reported.
-
Combination bevacizumab therapy demonstrated activity in heavily pretreated women with ovarian cancer. Gastrointestinal perforations were identified in 9%.
